Back to Search Start Over

Targeted protein relocalization via protein transport coupling.

Authors :
Ng CSC
Liu A
Cui B
Banik SM
Source :
Nature [Nature] 2024 Sep; Vol. 633 (8031), pp. 941-951. Date of Electronic Publication: 2024 Sep 18.
Publication Year :
2024

Abstract

Subcellular protein localization regulates protein function and can be corrupted in cancers <superscript>1</superscript> and neurodegenerative diseases <superscript>2,3</superscript> . The rewiring of localization to address disease-driving phenotypes would be an attractive targeted therapeutic approach. Molecules that harness the trafficking of a shuttle protein to control the subcellular localization of a target protein could enforce targeted protein relocalization and rewire the interactome. Here we identify a collection of shuttle proteins with potent ligands amenable to incorporation into targeted relocalization-activating molecules (TRAMs), and use these to relocalize endogenous proteins. Using a custom imaging analysis pipeline, we show that protein steady-state localization can be modulated through molecular coupling to shuttle proteins containing sufficiently strong localization sequences and expressed in the necessary abundance. We analyse the TRAM-induced relocalization of different proteins and then use nuclear hormone receptors as shuttles to redistribute disease-driving mutant proteins such as SMARCB1 <superscript>Q318X</superscript> , TDP43 <superscript>ΔNLS</superscript> and FUS <superscript>R495X</superscript> . TRAM-mediated relocalization of FUS <superscript>R495X</superscript> to the nucleus from the cytoplasm correlated with a reduction in the number of stress granules in a model of cellular stress. With methionyl aminopeptidase 2 and poly(ADP-ribose) polymerase 1 as endogenous cytoplasmic and nuclear shuttles, respectively, we demonstrate relocalization of endogenous PRMT9, SOS1 and FKBP12. Small-molecule-mediated redistribution of nicotinamide nucleotide adenylyltransferase 1 from nuclei to axons in primary neurons was able to slow axonal degeneration and pharmacologically mimic the genetic WldS gain-of-function phenotype in mice resistant to certain types of neurodegeneration <superscript>4</superscript> . The concept of targeted protein relocalization could therefore inspire approaches for treating disease through interactome rewiring.<br /> (© 2024. The Author(s), under exclusive licence to Springer Nature Limited.)

Details

Language :
English
ISSN :
1476-4687
Volume :
633
Issue :
8031
Database :
MEDLINE
Journal :
Nature
Publication Type :
Academic Journal
Accession number :
39294374
Full Text :
https://doi.org/10.1038/s41586-024-07950-8